Gene · 3741
Papers2,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative Study of Transcriptome in the Hearts Isolated from Mice, Rats, and Humans. | Biomolecules | 2022 | 35740984 | PubTator, text mining | PubMed |
| Toxic Effects and Tumor Promotion Activity of Marine Phytoplankton Toxins: A Review. | Toxins (Basel) | 2022 | 35737058 | PubTator, text mining | PubMed |
| Cm28, a scorpion toxin having a unique primary structure, inhibits KV1.2 and KV1.3 with high affinity. | J Gen Physiol | 2022 | 35699659 | PubTator, text mining | PubMed |
| A Review on the Role of TRP Channels and Their Potential as Drug Targets_An Insight Into the TRP Channel Drug Discovery Methodologies. | Front Pharmacol | 2022 | 35685622 | PubTator, text mining | PubMed |
| Design of New Potent and Selective Thiophene-Based KV1.3 Inhibitors and Their Potential for Anticancer Activity. | Cancers (Basel) | 2022 | 35681571 | PubTator, text mining | PubMed |
| Editorial: Interplays and Functions of Gaseous Mediators: From Underlying Mechanisms to Therapeutic Approaches in Cardiovascular Diseases. | Front Pharmacol | 2022 | 35677451 | PubTator, text mining | PubMed |
| Editorial: Novel Molecular Mechanisms and Innovative Therapeutic Approaches for Age-Associated Diseases. | Front Mol Biosci | 2022 | 35664669 | PubTator, text mining | PubMed |
| Is Arsenic Exposure a Risk Factor for Metabolic Syndrome? A Review of the Potential Mechanisms. | Front Endocrinol (Lausanne) | 2022 | 35651975 | PubTator, text mining | PubMed |
| Dapagliflozin induces vasodilation in resistance-size mesenteric arteries by stimulating smooth muscle cell KV7 ion channels. | Heliyon | 2022 | 35647331 | PubTator, text mining | PubMed |
| Distinctive mechanisms of epilepsy-causing mutants discovered by measuring S4 movement in KCNQ2 channels. | Elife | 2022 | 35642783 | PubTator, text mining | PubMed |
| Comparison of Losartan and Furosemide Interaction with HSA and Their Influence on HSA Antioxidant Potential. | Pharmaceuticals (Basel) | 2022 | 35631326 | PubTator, text mining | PubMed |
| Description of Two New Cases of AQP1 Related Pulmonary Arterial Hypertension and Review of the Literature. | Genes (Basel) | 2022 | 35627312 | PubTator, text mining | PubMed |
| Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity? | Genes (Basel) | 2022 | 35627145 | PubTator, text mining | PubMed |
| Pathophysiological Responses to Conotoxin Modulation of Voltage-Gated Ion Currents. | Mar Drugs | 2022 | 35621933 | PubTator, text mining | PubMed |
| Impact of High-Altitude Hypoxia on Bone Defect Repair: A Review of Molecular Mechanisms and Therapeutic Implications. | Front Med (Lausanne) | 2022 | 35620712 | PubTator, text mining | PubMed |
| Hyperthyroidism and the Risk of Cardiac Arrhythmias: A Narrative Review. | Cureus | 2022 | 35619859 | PubTator, text mining | PubMed |
| Three novel FHL1 variants cause a mild phenotype of Emery-Dreifuss muscular dystrophy. | Hum Mutat | 2022 | 35607917 | PubTator, text mining | PubMed |
| Recurrent ventricular fibrillation in a patient with inferolateral early repolarization and higher testosterone level. | HeartRhythm Case Rep | 2022 | 35607334 | PubTator, text mining | PubMed |
| Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective. | J Mol Med (Berl) | 2022 | 35606652 | PubTator, text mining | PubMed |
| Extended intergenic DNA contributes to neuron-specific expression of neighboring genes in the mammalian nervous system. | Nat Commun | 2022 | 35585070 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3741/papers?page=17